Abstract
Objectives
This study aimed to analyze the relationship between clinical status and work characteristics of firefighters and other public officers who engaged on collection duties in the site of the hydrogen fluoride spill that occurred on September 27, 2012, in Gumi City, South Korea.
Methods
We investigated the clinical status, personal history, and work characteristics of the study subjects and performed physical examination and several clinical examinations, including chest radiography, echocardiography, pulmonary function test, and blood testing in 348 firefighters, police officers, volunteer firefighters, and special warfare reserved force who worked at the hydrogen fluoride spill area.
Results
The subjects who worked near the accident site more frequently experienced eye symptoms (p=0.026), cough (p=0.017), and headache (p=0.003) than the subjects who worked farther from the accident site. The longer the working hours at the accident area, the more frequently the subjects experienced pulmonary (p=0.027), sputum (p=0.043), and vomiting symptoms (p=0.003). The subjects who did not wear respiratory protective devices more frequently experienced dyspnea than those who wore respiratory protective devices (p=0.013). In the pulmonary function test, the subjects who worked near the accident site had a higher decease in forced vital capacity than the subjects who worked farther from the site (p=0.019); however, no statistical association was found between serum calcium/phosphate level, echocardiography result, chest radiographic result, and probation work characteristics.
Conclusions
The subjects who worked near the site of the hydrogen fluoride spill, worked for an extended period, or worked without wearing respiratory protective devices more frequently experienced upper/lower respiratory, gastrointestinal, and neurological symptoms. Further follow-up examination is needed for the workers who were exposed to hydrogen fluoride during their collection duties in the chemical plant in Gumi City.
Key Words
Hydrofluoric acid, Chemical hazard release, FirefightersReferences
1. Korea Occupational Safety & Health Agency. Practice guideline of health examination for workers (translated by Cho SY) Incheon(Korean). Korea: Health Research Institute;2009. p. 2.
2. United States Environmental Protection Agency. Hydrogen fluoride study. 2012. http://www.epa.gov. cited 5 August 2012.
3. Wing JS, Brender JD, Sanderson LM, Perrotta DM, Beauchamp RA. Acute health effects in a community after a release of hydrofluoric acid. Arch Environ Health. 1991; 46(3):155–160. 23.
4. Wong A, Greene S, Robinson J. Hydrofluoric acid poisoning: data from the Victorian Poisons Information Centre. Emerg Med Australas. 2012; 24:98–101. 3.
5. Gumi City. Report of explosion accident in HUBE Global Inc(translated by Cho SY). 2013. www.gumi.go.kr. (cited 20 August 2013).3.
6. Lim HS, Lee K. Health care plan for hydrogen fluoride spill, Gumi, Korea. J Korean Med Sci. 2012; 27:1283–1284.
7. Na JY, Woo KH, Yoon SY, Cho SY, Song IU, Kim JA, Kim JS. Acute symptoms after community hydrogen fluoride spill. Ann Occup Environ Med. 2013; 25:17. 33.
8. Kim JM, Lee HJ. Hazard exposed to firefighter in fire- physical, chemical, and biological factors. J Korean Med Assoc. 2008; 51(12):1072–1077.
9. Won JW. Health and Firefighter(translated Cho SY). Korean Industrial Health Association. Korean. 2006; 214:18–25.
10. Jankovic J, Jones W, Burkhart J, Noonan G. Environmental study of firefighter. Ann Occup Hyg. 1991; 35(6):581–602.
11. Gyeongbuk Fire Service Headquaters. Briefing on the Initial Respose of Hydrogen Fluoride Spill (translated by Cho SY). 2013. www.gumi.go.kr. (cited 19 August 2013).
12. Yonhap News Agency. Hydrogen fluoride accident caused five hundred patients of firefighter, officials in Gumi(translated by Cho SY). 2013. http://www.ytn.co.kr/. (cited 5 August 2013).
13. Dayal HH, Brodwick M, Morris R, Baranowski T, Trieff N, Harrison JA, Lisse JR, Ansari GAS. A community based epidemiologic study of health sequelae of exposure to hydrofluoric acid. Ann Epidemiol. 1992; 2:213–230.
14. Himes JE. Occupational medicine in Oklahoma: hydrofluoric acid dangers. J Okla State Med Assoc. 1989; 82:567–569.
15. Lund K, Ekstrand J, Boe J, Søstrand P, Kongerud J. Exposure to hydrogen fluoride: an experimental study in humans of concentrations of fluoride in plasma, symptoms, and lung function. Occup Environ Med. 1997; 54:32–37.
16. Wu ML, Deng JF, Fan JS. Survival after hypocalcemia, hypomagnesemia, hypokalemia and cardiac arrest following mild hydrofluoric acid burn. J Clin Toxicol. 2010; 48:953–955.
17. Dünser MW, Ohlbauer M, Rieder J, Zimmermann I, Ruatti H, Schwabegger AH, Bodrogi F, Huemer GM, Friesenecker BE, Mayr AJ, Lirk P. Critical care management of major hydrofluoric acid burns: a case report, review of the literature, and recommendations for therapy. Burns. 2004; 30:391–398.
18. Lee JE, Suh BS, Jo SS, Lee WC. Hydrofluoric acid burns: a case report. Korean J Occup Environ Med. 2011; 23(2):225–233.
19. Blodgett DW, Suruda AJ, Crouch BI. Fatal unintentional occupational poisonings by hydrofluoric acid in the U.S. Am J Ind Med. 2001; 40:215–220.
20. Lim HS, Cheong HK, Kim JY. A study on occupational hydrofluoric acid burns in a hydrofluoric acid manufacturing factory. Korean J Prev Med. 1993; 26(4):587–598.
21. Seo IK, Kim SJ. A case of successful management of inhalation injury caused by hydrofluoric acid poisoning. Korean Soc Emerg Med. 2011; 22(1):116–120.
22. Lim IA, Sung JC. Occupational health and fitness for work of firefighters. J Korean Med Assoc. 2008; 51(12):1078–1086.
23. Gumi City. Briefing Data related to Hydrogen Fluoride Spill (translated by Cho SY). 2013. www.gumi.go.kr. (cited 19 August 2013).
24. Ministry of Environment. The result of Pollution Survey and Progress Situation related to Hydrogen Fluoride Spill. (translated by Cho SY). 2013. www.me.go.kr. (cited 19 August 2013).
Table 1
Less than 100 m (N=140) | 100 m-1 Km (N=173) | More than 1 Km (N=35) | p-value* | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Age (years) | 0.000 | ||||||
< 30 | 21 | 58.3 | 14 | 38.9 | 1 | 2.8 | |
30∼39 | 56 | 51.4 | 44 | 40.4 | 9 | 8.3 | |
40∼49 | 45 | 32.4 | 79 | 56.8 | 15 | 10.8 | |
≥ 50 | 18 | 28.1 | 36 | 56.3 | 10 | 15.6 | |
Gender | 0.031 | ||||||
Male | 138 | 42.1 | 157 | 47.9 | 33 | 10.1 | |
Female | 2 | 10.0 | 16 | 9.2 | 2 | 5.7 | |
Smoking | 0.532 | ||||||
No smoker | 100 | 42.2 | 112 | 47.3 | 25 | 10.5 | |
Current smoker | 40 | 36.0 | 61 | 55.0 | 10 | 9.0 | |
Job | 0.000 | ||||||
Firefighter | 116 | 47.3 | 102 | 41.6 | 27 | 11.0 | |
Police officer | 20 | 43.5 | 26 | 56.5 | 0 | 0.0 | |
Volunteer firefighter | 4 | 11.8 | 23 | 67.6 | 7 | 20.6 | |
Special warfare reserved force | 0 | 0.0 | 22 | 95.7 | 1 | 2.9 | |
Abnormal symptoms | |||||||
Throat† | 24 | 17.1 | 36 | 20.8 | 4 | 11.4 | 0.082 |
Nose‡ | 18 | 12.9 | 17 | 9.8 | 6 | 17.1 | 0.924 |
Eye§ | 42 | 30.0 | 30 | 17.3 | 7 | 20.0 | 0.026 |
Lung∥ | 49 | 35.0 | 50 | 28.9 | 8 | 22.9 | 0.115 |
Skin** | 15 | 10.7 | 20 | 11.6 | 3 | 8.6 | 0.886 |
Heart++ | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
Nerve‡‡ | 15 | 10.7 | 14 | 8.1 | 1 | 2.9 | 0.141 |
Stomach‡‡‡ | 4 | 2.9 | 5 | 2.9 | 1 | 2.9 | 0.993 |
Table 2
Less than 1 hours (N=28) | 1–10 hours (N=272) | More than 10 hours (N=48) | p-value* | ||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | ||
Age (years) | 0.972 | ||||||
< 30 | 1 | 2.8 | 30 | 83.3 | 5 | 13.9 | |
30∼ 39 | 13 | 11.9 | 77 | 70.6 | 19 | 17.4 | |
40∼ 49 | 11 | 7.9 | 114 | 82.0 | 14 | 10.1 | |
≥ 50 | 3 | 4.7 | 51 | 79.7 | 10 | 15.6 | |
Gender | 0.569 | ||||||
Male | 26 | 7.9 | 256 | 78.0 | 46 | 14.0 | |
Female | 2 | 10.0 | 16 | 80.0 | 2 | 10.0 | |
Smoking | 0.403 | ||||||
No smoker | 17 | 7.2 | 186 | 78.5 | 34 | 14.3 | |
Current smoker | 11 | 9.9 | 86 | 77.5 | 14 | 12.6 | |
Job | 0.001 | ||||||
Firefighter | 16 | 6.5 | 184 | 75.1 | 45 | 18.4 | |
Police officer | 7 | 15.2 | 36 | 78.3 | 3 | 6.5 | |
Volunteer firefighter | 4 | 11.8 | 30 | 88.2 | 0 | 0.0 | |
Special warfare reserved force | 1 | 4.3 | 22 | 95.7 | 0 | 0.0 | |
Abnormal symptoms | |||||||
Throat† | 8 | 28.6 | 45 | 16.5 | 22 | 22.9 | 0.840 |
Nose‡ | 3 | 10.7 | 30 | 11.0 | 8 | 16.7 | 0.344 |
Eye§ | 5 | 17.9 | 63 | 23.2 | 11 | 22.9 | 0.688 |
Lung∥ | 3 | 10.7 | 86 | 31.6 | 18 | 37.5 | 0.027 |
Skin** | 2 | 7.1 | 32 | 11.8 | 4 | 8.3 | 0.946 |
Heart++ | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
Nerve‡‡ | 1 | 3.6 | 22 | 8.1 | 7 | 14.6 | 0.079 |
Stomach‡‡‡ | 0 | 0.0 | 6 | 2.2 | 4 | 13.8 | 0.018 |
Table 3
No wear (N=91) | Disposable or cotton mask (N=114) | Gas mask (N=11) | SCBA (N= 132) | p-value* | |||||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | ||
Age (years) | 0.000 | ||||||||
< 30 | 5 | 13.9 | 8 | 22.2 | 2 | 5.6 | 21 | 58.3 | |
30∼ 39 | 22 | 20.2 | 33 | 30.3 | 2 | 1.8 | 52 | 47.7 | |
40∼ 49 | 47 | 33.8 | 46 | 33.1 | 4 | 2.9 | 42 | 30.2 | |
≥ 50 | 17 | 26.6 | 27 | 42.2 | 3 | 4.7 | 17 | 26.6 | |
Gender | 0.012 | ||||||||
Male | 81 | 24.7 | 108 | 32.9 | 10 | 3.0 | 129 | 39.3 | |
Female | 10 | 50.0 | 6 | 30.0 | 1 | 5.0 | 3 | 15.0 | |
Smoking | 0.101 | ||||||||
No smoker | 56 | 23.6 | 79 | 33.3 | 5 | 2.1 | 97 | 40.9 | |
Current smoker | 35 | 31.5 | 35 | 31.5 | 6 | 5.4 | 35 | 31.5 | |
Job | 0.000 | ||||||||
Firefighter | 51 | 20.8 | 59 | 24.1 | 3 | 1.2 | 132 | 53.9 | |
Police officer | 16 | 34.8 | 22 | 47.8 | 8 | 17.4 | 0 | 0.0 | |
Volunteer firefighter | 21 | 61.8 | 13 | 38.2 | 0 | 0.0 | 0 | 0.0 | |
Special warfare reserved force | 3 | 13.0 | 20 | 87.0 | 0 | 0.0 | 0 | 0.0 | |
Abnormal symptoms | |||||||||
Throat† | 13 | 14.3 | 21 | 18.4 | 3 | 27.3 | 27 | 20.5 | 0.262 |
Nose‡ | 10 | 11.0 | 12 | 10.5 | 1 | 9.1 | 18 | 13.6 | 0.468 |
Eye§ | 21 | 23.1 | 19 | 16.7 | 2 | 18.2 | 37 | 28.0 | 0.139 |
Lung∥ | 34 | 37.4 | 33 | 28.9 | 4 | 36.4 | 36 | 27.3 | 0.208 |
Skin** | 5 | 5.5 | 19 | 16.7 | 1 | 9.1 | 13 | 9.8 | 0.977 |
Heart++ | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | 0 | 0.0 | – |
Nerve‡‡ | 9 | 9.9 | 8 | 7.0 | 0 | 0.0 | 13 | 9.8 | 0.840 |
Stomach‡‡‡ | 0 | 0.0 | 7 | 6.1 | 0 | 0.0 | 3 | 2.3 | 0.941 |
Table 4
Less than 100 m (N= 140) | 100 m-1 Km (N=173) | More than 1 Km (N=35) | Total | p-value* | |||||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | ||
Throat | |||||||||
Throat pain | 24 | 10.8 | 36 | 17.1 | 4 | 11.8 | 64 | 13.7 | 0.882 |
Nose | |||||||||
Rhinorreha | 15 | 6.8 | 13 | 6.2 | 4 | 11.8 | 32 | 6.9 | 0.698 |
Nasal obstruction | 5 | 2.3 | 2 | 1.0 | 2 | 5.9 | 9 | 1.9 | 0.881 |
Nasal pain | 1 | 0.5 | 2 | 1.0 | 0 | 0.0 | 3 | 0.6 | 0.932 |
Eye | |||||||||
Ocular pain | 28 | 12.6 | 22 | 10.5 | 5 | 14.7 | 55 | 11.8 | 0.143 |
Red eye | 7 | 3.2 | 5 | 2.4 | 0 | 0.0 | 12 | 2.6 | 0.122 |
Blurred vision | 4 | 1.8 | 4 | 1.9 | 2 | 5.9 | 10 | 2.1 | 0.612 |
Lacrimination | 6 | 2.7 | 3 | 1.4 | 0 | 0.0 | 9 | 1.9 | 0.084 |
Lung | |||||||||
Cough | 32 | 14.4 | 29 | 13.8 | 2 | 5.9 | 63 | 13.5 | 0.017 |
Sputum | 17 | 7.7 | 20 | 9.5 | 4 | 11.8 | 41 | 8.8 | 0.871 |
Chest discomfort | 16 | 7.2 | 12 | 5.7 | 2 | 5.9 | 30 | 6.4 | 0.141 |
Dyspnea | 1 | 0.5 | 1 | 0.5 | 2 | 5.9 | 4 | 0.9 | 0.084 |
Skin | |||||||||
Skin pruritus | 10 | 4.5 | 9 | 4.3 | 2 | 5.9 | 21 | 4.5 | 0.560 |
Skin rash | 6 | 2.7 | 6 | 2.9 | 0 | 0.0 | 12 | 2.6 | 0.227 |
Skin pain | 0 | 0.0 | 6 | 2.9 | 1 | 2.9 | 7 | 1.5 | 0.064 |
Nerve | |||||||||
Fatigue | 17 | 7.7 | 15 | 7.1 | 0 | 0.0 | 32 | 6.9 | 0.034 |
Headache | 19 | 8.6 | 11 | 5.2 | 0 | 0.0 | 30 | 6.4 | 0.003 |
Dizziness | 5 | 2.3 | 1 | 0.5 | 1 | 2.9 | 7 | 1.5 | 0.262 |
Arm/leg claudication | 2 | 0.9 | 4 | 1.9 | 0 | 0.0 | 6 | 1.3 | 0.903 |
Stomach | |||||||||
Vomiting | 3 | 1.4 | 3 | 1.4 | 1 | 2.9 | 7 | 1.5 | 0.947 |
Other | 4 | 1.8 | 6 | 2.9 | 2 | 5.9 | 12 | 2.6 | 0.459 |
Total | 222 | 100.0 | 210 | 100.0 | 34 | 100.0 | 466 | 100.0 |
Table 5
Less than 1 hours (N= 28) | 1–10 hours (N=272) | More than 10 hours (N=48) | Total | p-value* | |||||
---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | N | % | ||
Throat | |||||||||
Throat pain | 8 | 32.0 | 45 | 12.6 | 11 | 13.3 | 64 | 13.7 | 0.840 |
Nose | |||||||||
Rhinorreha | 2 | 8.0 | 23 | 6.4 | 7 | 8.4 | 32 | 6.9 | 0.207 |
Nasal obstruction | 1 | 4.0 | 6 | 1.7 | 2 | 2.4 | 9 | 1.9 | 0.726 |
Nasal pain | 0 | 0.0 | 3 | 0.8 | 0 | 0.0 | 3 | 0.6 | 0.830 |
Eye | |||||||||
Ocular pain | 4 | 16.0 | 45 | 12.6 | 6 | 7.2 | 55 | 11.8 | 0.713 |
Red eye | 1 | 4.0 | 10 | 2.8 | 1 | 1.2 | 12 | 2.6 | 0.663 |
Blurred vision | 0 | 0.0 | 7 | 2.0 | 3 | 3.6 | 10 | 2.1 | 0.094 |
Lacrimination | 0 | 0.0 | 7 | 2.0 | 2 | 2.4 | 9 | 1.9 | 0.281 |
Lung | |||||||||
Cough | 2 | 8.0 | 49 | 13.7 | 12 | 14.5 | 63 | 13.5 | 0.056 |
Sputum | 0 | 0.0 | 33 | 9.2 | 8 | 9.6 | 41 | 8.8 | 0.043 |
Chest discomfort | 1 | 4.0 | 24 | 6.7 | 5 | 6.0 | 30 | 6.4 | 0.349 |
Dyspnea | 0 | 0.0 | 4 | 1.1 | 0 | 0.0 | 4 | 0.9 | 0.803 |
Skin | |||||||||
Skin pruritus | 2 | 8.0 | 18 | 5.0 | 1 | 1.2 | 21 | 4.5 | 0.285 |
Skin rash | 1 | 4.0 | 9 | 2.5 | 2 | 2.4 | 12 | 2.6 | 0.884 |
Skin pain | 0 | 0.0 | 6 | 1.7 | 1 | 1.2 | 7 | 1.5 | 0.623 |
Nerve | |||||||||
Fatigue | 2 | 8.0 | 21 | 5.9 | 9 | 10.8 | 32 | 6.9 | 0.039 |
Headache | 1 | 4.0 | 23 | 6.4 | 6 | 7.2 | 30 | 6.4 | 0.178 |
Dizziness | 0 | 0.0 | 5 | 1.4 | 2 | 2.4 | 7 | 1.5 | 0.189 |
Arm/leg claudication | 0 | 0.0 | 6 | 1.7 | 0 | 0.0 | 6 | 1.3 | 0.760 |
Stomach | |||||||||
Vomiting | 0 | 0.0 | 3 | 0.8 | 4 | 4.8 | 7 | 1.5 | 0.003 |
Other | 0 | 0.0 | 11 | 3.1 | 1 | 1.2 | 12 | 2.6 | 0.844 |
Total | 25 | 100.0 | 358 | 100.0 | 83 | 173.2 | 466 | 100.0 |
Table 6
Characteristic | Less than 100 m (N=140) Mean ± SD | 100 m-1 Km (N=173) Mean ± SD | More than 1 Km (N= 35) Mean ± SD | p-value* |
---|---|---|---|---|
Serum electrolyte | ||||
Calcium (mg/dL) | 9.41±0.37 | 9.41±0.37 | 9.45±0.36 | 0.579 |
Phosphorus (mg/dL) | ) 3.44±0.70 | 3.44±0.46 | 3.37±0.35 | 0.767 |
Spirometry† | ||||
FVC (L) | 4.50±0.67 | 4.36±0.75 | 4.59±0.86 | 0.019 |
FVC% (%) | 90.57±10.01 | 90.68±11.35 | 95.66±11.43 | 0.019 |
FEV1 (L) | 3.67±0.60 | 3.55±0.62 | 3.64±0.67 | 0.060 |
FEV1% (%) | 91.80±10.97 | 92.54±11.61 | 95.60±12.58 | 0.104 |
FEV1/FVC | 81.63± 6.56 | 81.58±6.02 | 79.45±6.05 | 0.257 |
FEF25–75 (L) | 3.70±1.08 | 3.59±0.97 | 3.40±0.97 | 0.366 |
FEF25–75% (%) | 95.20±24.59 | 97.57±23.85 | 94.80±27.98 | 0.568 |